WEYERHAEUSER CO
For the period ended Sep 30, 2024. Filed Oct 25, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Oct 25, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
NET EARNINGS PER SHARE AND SHARE REPURCHASES
NOTE 4: NET EARNINGS PER SHARE AND SHARE REPURCHASES
Our basic and diluted earnings per share were:
$0.04 during third quarter 2024 and$0.43 during year-to-date 2024;
$0.33 during third quarter 2023 and$0.85 during year-to-date 2023.
Basic earnings per share is net earnings divided by the weighted average number of our outstanding common shares, including stock equivalent units where there is no circumstance under which those shares would not be issued. Diluted earnings per share is net earnings divided by the sum of the weighted average number of our outstanding common shares and the effect of our outstanding dilutive potential common shares.
| QUARTER ENDED | YEAR-TO-DATE ENDED | |||
|---|---|---|---|---|
| SHARES IN THOUSANDS | SEPTEMBER 2024 | SEPTEMBER 2023 | SEPTEMBER 2024 | SEPTEMBER 2023 |
| Weighted average common shares outstanding – basic | 727,621 | 731,046 | 728,892 | 732,069 |
| Dilutive potential common shares: | ||||
| Stock options | 95 | 154 | 115 | 134 |
| Restricted stock units | 329 | 304 | 203 | 117 |
| Performance share units | 135 | 238 | 145 | 222 |
| Total effect of outstanding dilutive potential common shares | 559 | 696 | 463 | 473 |
| Weighted average common shares outstanding – dilutive | 728,180 | 731,742 | 729,355 | 732,542 |
We use the treasury stock method to calculate the dilutive effect of our outstanding stock options, restricted stock units and performance share units.
Potential Shares Not Included in the Computation of Diluted Earnings per Share
The following shares were not included in the computation of diluted earnings per share because they were either antidilutive or the required performance or market conditions were not met. Some or all of these shares may be dilutive potential common shares in future periods.
| QUARTER ENDED | YEAR-TO-DATE ENDED | |||
|---|---|---|---|---|
| SHARES IN THOUSANDS | SEPTEMBER 2024 | SEPTEMBER 2023 | SEPTEMBER 2024 | SEPTEMBER 2023 |
| Stock options | 607 | 609 | 607 | 609 |
| Performance share units | 892 | 612 | 892 | 612 |
Share Repurchase Program
On September 22, 2021, we announced that our board of directors approved a new share repurchase program (the 2021 Repurchase Program) under which we are authorized to repurchase up to $1 billion of outstanding shares. Concurrently, the board terminated the remaining repurchase authorization under the share repurchase program approved by the board in February 2019 (the 2019 Repurchase Program).
We repurchased 820,706 common shares for approximately$26 million (including transaction fees) under the 2021 Repurchase Program during third quarter 2024 and 3,962,220 common shares for approximately$125 million (including transaction fees) under the 2021 Share Repurchase Program during year-to-date 2024. During third quarter 2023, we repurchased 757,510 common shares for approximately $25 million (including transaction fees) and 3,562,944 common shares for approximately $110 million (including transaction fees) during year-to-date 2023 under the 2021 Repurchase Program. As of September 30, 2024, we had remaining authorization of$127 million for future share repurchases.
All common stock repurchases under the 2021 Repurchase Program were made in open-market transactions. We record share repurchases upon trade date as opposed to the settlement date when cash is disbursed. We record a liability for repurchases that have not yet been settled as of period end. There were 11,564 unsettled shares (less than $1 million) as of September 30, 2024 and 13,866 unsettled shares (approximately $1 million) as of December 31, 2023.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.